The ONE THING That Appeared During COVID

13 Dec 2024 · 1 min

Watch on YouTube

0:54

This content was created by Matt Kelly. This content was uploaded by Matt Kelly. This is a YouTube video titled "The ONE THING That Appeared During COVID" (created 2024-12-13) containing an English, single‑speaker medical commentary (speaker labeled SPEAKER A). The speaker—likely a clinician or medical expert—discusses laboratory monitoring in the context of COVID, emphasizing elevated clotting markers (D‑dimer, fibrinogen), tests for hypercoagulability and microclots (lungs, brain), global inflammatory markers (ESR, CRP), and chemistry panel components including alkaline phosphatase and LDH (noting LDH as a marker of hypoxic metabolism). The advice is to check these markers early and follow them if elevated.

Chapters

The next thing that is super critical to follow is in the world of COVID that we've been in, we've seen elevations in people's clotting factors that, you know, aren't necessarily due to all of the normal reasons, but things like the D-dimer and fibrinogen. There's different tests in around fibrinogen that you can look at, but those should be looked at in the beginning and certainly followed if they're elevated because you might be more at risk for clotting or you might be one of these people getting microclots in the lungs, for example, or the brain or something. So that's something to look at early on. Global inflammatory markers like either sedimentation rate or CRP. And then if it wasn't included in the metabolic panel, the chemistry panel, normally there is alkaline phosphatase included in there, but also LDH. If it wasn't, we make sure both of those are in. So the LDH is looking more at hypoxic metabolism.